[Extracorporeal photochemotherapy or immunotherapy using cells modified by photochemistry].
Extracorporeal photochemotherapy (ECP) is an autologous cell therapy used for the treatment of diseases involving pathogenic cells: cutaneous T-cell lymphoma, organ rejection and graft versus host disease. During an ECP procedure, patients receive a cellular product consisting of autologous mononuclear cells, containing the pathogenic cells, treated with a photosensitising agent and an UV-A radiation. The aim of the treatment is to induce a specific immune reaction modulating the activity of untreated pathogenic lymphocytes responsible for the disease and therefore an improvement of clinical manifestations. The precise mechanisms of action remain to be defined in humans. Its efficacy coupled with the absence of side effects could lead to decrease the use of immunosuppressive drugs. PCE appears as an immunotherapy using cells modified by photochemistry, which allows specific immune modulation of pathogenic lymphocytes.
Université Joseph-Fourier, Grenoble, France. joel.plumas@wanadoo.fr
D
D
Hannani
F
F
Gabert
L
L
Chaperot
M J
MJ
Richard
J
J
Plumas
D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D055668:Photochemical Processes; D017893:Photopheresis